| Secondary |
| Product Used For Unknown Indication |
38.1% |
| Hepatitis C |
18.6% |
| Parenteral Nutrition |
14.4% |
| Emphysema |
6.2% |
| Asthenia |
3.1% |
| Nutritional Supplementation |
3.1% |
| Renal Failure Chronic |
3.1% |
| Carcinoid Tumour |
2.1% |
| Clonus |
2.1% |
| Hemiplegia |
2.1% |
| Nutritional Support |
2.1% |
| Haemoptysis |
1.0% |
| Oesophagitis |
1.0% |
| Pain |
1.0% |
| Post Herpetic Neuralgia |
1.0% |
| Prophylaxis Against Diarrhoea |
1.0% |
|
| Injection Site Induration |
21.1% |
| Hypophagia |
15.8% |
| Fungal Peritonitis |
10.5% |
| Inflammation |
10.5% |
| Blood Glucose Increased |
5.3% |
| Hypersensitivity |
5.3% |
| Hypertriglyceridaemia |
5.3% |
| Marasmus |
5.3% |
| Nasogastric Output High |
5.3% |
| Oedema |
5.3% |
| Thrombocytopenia |
5.3% |
| Tremor |
5.3% |
|
| Concomitant |
| Product Used For Unknown Indication |
39.4% |
| Drug Use For Unknown Indication |
22.4% |
| Prophylaxis |
8.7% |
| Pain Management |
3.2% |
| Multiple Myeloma |
2.7% |
| Aplastic Anaemia |
2.7% |
| Pneumonia |
2.1% |
| Premedication |
1.9% |
| Colorectal Cancer Metastatic |
1.8% |
| Hypertension |
1.7% |
| Infection Prophylaxis |
1.5% |
| Decreased Appetite |
1.5% |
| Pain |
1.5% |
| Diabetes Mellitus |
1.4% |
| Non-small Cell Lung Cancer |
1.3% |
| Osteoporosis |
1.3% |
| Supplementation Therapy |
1.3% |
| Anorexia |
1.2% |
| Glioblastoma |
1.2% |
| Hepatic Cirrhosis |
1.2% |
|
| Sepsis |
10.6% |
| Wheezing |
7.4% |
| Nephrogenic Anaemia |
6.4% |
| Shock |
6.4% |
| Weight Decreased |
6.4% |
| Hepatic Function Abnormal |
5.3% |
| Septic Shock |
5.3% |
| Thrombocytopenia |
5.3% |
| Headache |
4.3% |
| Performance Status Decreased |
4.3% |
| Pyrexia |
4.3% |
| Rash |
4.3% |
| Renal Impairment |
4.3% |
| Therapeutic Response Decreased |
4.3% |
| Toxicity To Various Agents |
4.3% |
| Weight Increased |
4.3% |
| Bone Marrow Failure |
3.2% |
| Hepatic Encephalopathy |
3.2% |
| Hepatic Failure |
3.2% |
| Oedema Peripheral |
3.2% |
|
| Interacting |
| Alopecia |
50.0% |
| Drug Use For Unknown Indication |
50.0% |
|
| Drug Level Increased |
100.0% |
|
